e-learning
resources
Milan 2017
Tuesday, 12.09.2017
ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
G. Verleden (Leuven, Belgium)
Source:
International Congress 2017 – ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Session:
ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Session type:
Meet the expert
Number:
4325
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Verleden (Leuven, Belgium). Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?. International Congress 2017 – ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation?
Source: Milan 2017 - Educational material
Year: 2017
Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?
Source: Eur Respir J 2013; 41: 243-245
Year: 2013
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes
Source: Eur Respir J 2012; 40: 377-385
Year: 2012
Pleuroparenchymal fibroelastosis: one more walk on the wild side of drugs?
Source: Eur Respir J 2014; 44: 289-296
Year: 2014
Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 328s
Year: 2003
Pleuroparenchymal fibroelastosis: report of 4 cases
Source: International Congress 2017 – Rare diseases
Year: 2017
Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?
Source: Eur Respir J 2015; 45: 1183-1186
Year: 2015
Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006
Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Architectural remodelling in idiopathic interstitial pneumonias: fibrosis or fibroelastosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 557s
Year: 2004
Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018
Rare indications for lung transplantation
Source: Eur Respir Mon 2011; 54: 332-340
Year: 2011
Bilateral lung transplantation for pulmonary amyloidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 296s
Year: 2001
Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007
Lung transplantation for lymphangioleiomyomatosis: the European experience
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept